EW $138.98 +1.11 (0.81%)
Edwards Lifesciences Corp
Edwards Lifesciences Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $146.73 which is 5.28% above the stock price of $138.98.
200 Day Moving Average
The 200 Day Moving Average is at 131.75 which is -5.49% above the stock price of $138.98.
Because the stock price is between the 50 DMA and 200 DMA, look at other support and resistance trendlines.
EW Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $138.98.
The Year To Date (YTD) return is +24.56%.
52 Week Low
The 52 Week Low stock price is $100.20 set on Mon, Oct 30, 2017 which is 290 days ago.
The current price per share is 38.70% above the 52 week low.
52 Week High
The 52 Week High stock price is $156.87 set on Thu, Jul 26, 2018 which is 21 days ago.
The current price per share is -11.40% below the 52 week high.
All Time High
The All Time High stock price is $156.87 set on Thu, Jul 26, 2018 which is 21 days ago.
The current price per share is -11.40% below the all time high.
Below is the EPS, P/E Ratio and Earnings Date.
The Earnings Per Share (EPS) is $3.05.
The Price To Earnings (P/E) Ratio is 45.34.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Edwards Lifesciences Corp was Tue, Apr 24, 2018.
Since this earnings release 114 days ago, the stock price is up by +1.30%.
The most recent Earnings Release Date was on Thu, Jul 26, 2018, which was 21 days ago.
Since this earnings date, the stock price is down by -10.40%.
Edwards Lifesciences Dividend
Below is important Dividend information.
EW currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.
Medical Equipment & Devices Industry
Below are other stocks in the same industry as Edwards Lifesciences.
EW Company Profile
Learn more about Edwards Lifesciences.
Edwards Lifesciences Corp is a Health Care stock that trades on the NYSE and has a market capitalization of $28.71 Billion.
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.
Spend a few minutes browsing the Edwards Lifesciences Corp, web site at http://www.edwards.com.